Clinical Trial Update: Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the prophylactic use of Levosimendan versus Milrinone to prevent low cardiac output syndrome in infants undergoing open-heart s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Cardiac Output Syndrome

Drugs mentioned

• Levosimendan (levosimendan)
• Milrinone (milrinone)

Snippet

Sponsor: Ludwig Boltzmann Gesellschaft | Conditions: Low Cardiac Output Syndrome | Phase 2 | Status: UNKNOWN